Ali Behbahani
Chairman en NKARTA, INC. .
Fortuna: 800 419 $ al 31/03/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Samarth Kulkarni | M | 45 | 9 años | |
Malik Kahook | M | - |
ClarVista Medical, Inc.
ClarVista Medical, Inc. Medical SpecialtiesHealth Technology ClarVista Medical, Inc. operates as a medical device company which focuses on the novel solutions in ophthalmology. It develops the harmoni modular intra-ocular lens systems to optimize vision in the setting of cataract surgery. The company was founded by Paul McLean and Robert E. Atkinson in 2012 and is headquartered in Aliso Viejo, CA.
SpyGlass Pharma Inc
SpyGlass Pharma Inc Miscellaneous Commercial ServicesCommercial Services Spyglass Ophthalmics, Inc. develops products for vision and eye care. The company was founded by Malik Y. Kahook and Glenn Sussman and is headquartered in Mission Viejo, CA. | 5 años |
Rami Elghandour | M | 45 | 12 años | |
Alexander Mayweg | M | 49 |
Launchpad Therapeutics, Inc.
Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Launchpad Therapeutics, Inc. develops novel therapeutics. | 7 años |
Bradley Bolzon | M | 64 |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | 10 años |
Ram Aiyar | M | - |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | 4 años |
David Mott | M | 58 |
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich.
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 16 años |
Simeon George | M | 46 | 9 años | |
Glenn Sussman | M | - |
SpyGlass Pharma Inc
SpyGlass Pharma Inc Miscellaneous Commercial ServicesCommercial Services Spyglass Ophthalmics, Inc. develops products for vision and eye care. The company was founded by Malik Y. Kahook and Glenn Sussman and is headquartered in Mission Viejo, CA.
ClarVista Medical, Inc.
ClarVista Medical, Inc. Medical SpecialtiesHealth Technology ClarVista Medical, Inc. operates as a medical device company which focuses on the novel solutions in ophthalmology. It develops the harmoni modular intra-ocular lens systems to optimize vision in the setting of cataract surgery. The company was founded by Paul McLean and Robert E. Atkinson in 2012 and is headquartered in Aliso Viejo, CA. | - |
Carlo Rizzuto | M | 53 |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022.
FirstLight Bio, Inc.
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | - |
Nessan Bermingham | M | 51 |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | 6 años |
Clare Ozawa | M | 50 |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA.
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | 5 años |
Jeffrey A. Stafford | M | - |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | 5 años |
Kevin Hykes | M | 58 | 2 años | |
Robert E. Atkinson | M | - |
Ocutherix, Inc.
Ocutherix, Inc. Medical SpecialtiesHealth Technology Ocutherix, Inc. operates as a medical device incubator which focuses on novel medical technologies. The firm serves the ophthalmology, cardiology, mobile health, orthopedics, neurology, pulmonology and metabolic clinical solutions. The company was founded by Robert E. Atkinson in 2005 and is headquartered in Stillwater, MN. | 19 años |
Adrian Rawcliffe | M | 52 | 9 años | |
Mark Velleca | M | 60 | 3 años | |
Vineet Agarwal | M | - |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | 3 años |
Jean-Francois Formela | M | 67 |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | 6 años |
Kevin T. Sprott | M | - |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | - |
David Epstein | M | 65 | 10 años | |
Scott Sandell | M | 59 |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | - |
Elliot Norry | M | 61 | 9 años | |
John Nehra | M | 76 |
Ocutherix, Inc.
Ocutherix, Inc. Medical SpecialtiesHealth Technology Ocutherix, Inc. operates as a medical device incubator which focuses on novel medical technologies. The firm serves the ophthalmology, cardiology, mobile health, orthopedics, neurology, pulmonology and metabolic clinical solutions. The company was founded by Robert E. Atkinson in 2005 and is headquartered in Stillwater, MN. | 7 años |
Markus Warmuth | M | 53 | 4 años | |
Helena Tayton-Martin | M | 57 | 16 años | |
Kashif Rashid | M | 50 | 7 años | |
Elizabeth Buck | M | 49 | 10 años | |
Garry Menzel | M | 59 | 10 años | |
Tony Florence | M | 55 |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 16 años |
Steve Goedeke | M | - |
Cardionomic, Inc.
Cardionomic, Inc. Medical/Nursing ServicesHealth Services Cardionomic, Inc. engages in the development of medical devices. The company was founded in 2011 and is headquartered in New Brighton, MN. | 12 años |
John Lunger | M | 55 | 7 años | |
Kavita Patel | M | 50 |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 7 años |
J. Randy Alexander | M | - |
Ivantis, Inc.
Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | - |
Fouad Azzam | M | 57 |
Rotation Medical, Inc.
Rotation Medical, Inc. Medical SpecialtiesHealth Technology Rotation Medical, Inc. develops treatment of rotator cuff disease. It includes a bioinductive implant and a set of disposable arthroscopic instruments that has been shown to heal tendons by inducing the growth of new tendon-like tissue. The company was founded by Thomas R. Hektner in 2009 and is headquartered in Plymouth, MN. | 5 años |
Cynthia Yee | F | - |
SpyGlass Pharma Inc
SpyGlass Pharma Inc Miscellaneous Commercial ServicesCommercial Services Spyglass Ophthalmics, Inc. develops products for vision and eye care. The company was founded by Malik Y. Kahook and Glenn Sussman and is headquartered in Mission Viejo, CA.
ClarVista Medical, Inc.
ClarVista Medical, Inc. Medical SpecialtiesHealth Technology ClarVista Medical, Inc. operates as a medical device company which focuses on the novel solutions in ophthalmology. It develops the harmoni modular intra-ocular lens systems to optimize vision in the setting of cataract surgery. The company was founded by Paul McLean and Robert E. Atkinson in 2012 and is headquartered in Aliso Viejo, CA.
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 4 años |
Andrew Schiff | M | 58 | 4 años | |
Charles A. Gersbach | M | - |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Akira Matsuno | M | - |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Mohamad Hassan Makhzoumi | M | 44 |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 19 años |
Jude Faulkner | M | - |
Rotation Medical, Inc.
Rotation Medical, Inc. Medical SpecialtiesHealth Technology Rotation Medical, Inc. develops treatment of rotator cuff disease. It includes a bioinductive implant and a set of disposable arthroscopic instruments that has been shown to heal tendons by inducing the growth of new tendon-like tissue. The company was founded by Thomas R. Hektner in 2009 and is headquartered in Plymouth, MN. | - |
Paul Hastings | M | 64 | 6 años | |
Jane Huang | M | 51 |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | 2 años |
Kimberly Blackwell | M | 55 | 4 años | |
Fang Ni | M | 37 | 4 años | |
Joanna Brewer | M | 47 | 15 años | |
Jennifer Champoux | F | - | 3 años | |
Steve Colletti | M | - |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | 1 años |
Olivia Ware | F | 67 | 2 años | |
James Veal | M | - |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | 5 años |
Lily Huang | F | - |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 7 años |
Christopher Christoforou | M | 54 | 8 años | |
Shelby Walker | F | - | 1 años | |
Matt Kane | M | - |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Danielle Lay | F | - |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 7 años |
Erika Jones | F | 39 | 5 años | |
Carmen Chang | F | 76 |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 11 años |
Zach Scheiner | M | 47 | 4 años | |
Scott Kanner | M | - |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | - |
Brian Bowman | M | - |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | - |
Harold Edward Fleming | M | 61 | 3 años | |
Jared Oasheim | M | 41 | 9 años | |
Andrew Fraley | M | - |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | - |
Angela Thedinga | F | 42 | 2 años | |
C. Kramlich | M | 89 |
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | 46 años |
Raju Prasad | M | 40 | 1 años | |
Mudit Jain | M | 55 | 4 años | |
Michael DeMane | M | 67 |
Cardionomic, Inc.
Cardionomic, Inc. Medical/Nursing ServicesHealth Services Cardionomic, Inc. engages in the development of medical devices. The company was founded in 2011 and is headquartered in New Brighton, MN.
Rotation Medical, Inc.
Rotation Medical, Inc. Medical SpecialtiesHealth Technology Rotation Medical, Inc. develops treatment of rotator cuff disease. It includes a bioinductive implant and a set of disposable arthroscopic instruments that has been shown to heal tendons by inducing the growth of new tendon-like tissue. The company was founded by Thomas R. Hektner in 2009 and is headquartered in Plymouth, MN. | - |
Leone Patterson | F | 61 | 4 años | |
Louis Citron | M | - |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | 23 años |
Doug Treco Treco | M | 66 | 4 años | |
Joseph Slattery | M | 59 | 16 años | |
Bruce Feuchter | M | - |
Ivantis, Inc.
Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | - |
David Lubner | M | 60 | 4 años | |
Tara Butler | M | - |
Cardionomic, Inc.
Cardionomic, Inc. Medical/Nursing ServicesHealth Services Cardionomic, Inc. engages in the development of medical devices. The company was founded in 2011 and is headquartered in New Brighton, MN.
Ivantis, Inc.
Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | 6 años |
David Shook | M | 46 | 4 años | |
Brent Hatzis-Schoch | M | 59 | 5 años | |
Chandra Paul Leo | M | 53 | 4 años | |
Kirk Nielsen | M | 50 | 4 años | |
John R. Brintnall | M | 71 | 21 años | |
Timothy Pearson | M | 56 | 1 años | |
Martha Shadan | F | 68 | 3 años | |
John Greene | M | 58 | 5 años | |
John Furey | M | 59 | 6 años | |
Shawn McCormick | M | 59 | 10 años | |
Kapil Dhingra | M | 64 | 3 años | |
Greg Mann | M | - | 4 años | |
Jonathan Terrett | M | - | 7 años | |
Alicia Hager | M | 54 | 4 años | |
Jim Kasinger | M | 52 | 7 años | |
Anthony Manning | M | 62 | 1 años | |
John Castle | M | 54 | 4 años | |
Maria Fardis | M | 56 | 2 años | |
Lawrence Alleva | M | 74 | 9 años | |
Gretchen Bain | M | - |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | 5 años |
Jan Skvarka | M | 57 | 1 años | |
Katherine High | M | 72 | 5 años | |
Jill Carroll | F | 48 | 7 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Rodger Novak | M | 56 | 10 años | |
Tiba Aynechi | M | 48 | 1 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 83 | 83.00% |
Suiza | 12 | 12.00% |
Reino Unido | 9 | 9.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Ali Behbahani
- Red Personal